home All News open_in_new Full Article

China’s Akeso gets share boost as data shows cancer drug’s benefits

Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose after the company unveiled clinical-trial data showing that its lung-cancer drug outperformed a highly effective existing treatment. The data showed that ivonescimab had “a decisive and strong positive outcome with both significant and clinically meaningful benefits”, Akeso said in a filing with the Hong Kong stock exchange on Monday. The drug, used along with...


today 37 h. ago attach_file Events

attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Science
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events


ID: 4185237545
Add Watch Country

arrow_drop_down